Detection of Tumour-Targeted IRDye800CW Tracer with Commercially Available Laparoscopic Surgical Systems

(1) Introduction: Near-infrared fluorescence (NIRF) combined with tumour-targeted tracers, such as bevacizumab-800CW, could aid surgical decision-making. This study explored the use of IRDye800CW, conjugated to bevacizumab, with four commercially available NIRF laparoscopes optimised for indocyanine...

Descripción completa

Detalles Bibliográficos
Autores principales: Sikkenk, Daan J., Sterkenburg, Andrea J., Schmidt, Iris, Gorpas, Dimitris, Nagengast, Wouter B., Consten, Esther C. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178288/
https://www.ncbi.nlm.nih.gov/pubmed/37174982
http://dx.doi.org/10.3390/diagnostics13091591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178288/
https://www.ncbi.nlm.nih.gov/pubmed/37174982
http://dx.doi.org/10.3390/diagnostics13091591

Ejemplares similares